Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected >600 million people in the ongoing global pandemic. Several variants of the SARS-CoV-2 have emerged in the last >2 years, challenging the continued efficacy of current COVID vaccines. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Raj S., Agrawal, Babita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272440/
https://www.ncbi.nlm.nih.gov/pubmed/37334376
http://dx.doi.org/10.3389/fimmu.2023.1178523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272440/
https://www.ncbi.nlm.nih.gov/pubmed/37334376
http://dx.doi.org/10.3389/fimmu.2023.1178523

Ejemplares similares